Dexco (DXCO3) Aktienübersicht
Dexco S.A. ist zusammen mit seinen Tochtergesellschaften in der Herstellung und dem Verkauf von Holzplatten in Brasilien und international tätig. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 5/6 |
| Künftiges Wachstum | 3/6 |
| Vergangene Leistung | 0/6 |
| Finanzielle Gesundheit | 1/6 |
| Dividenden | 0/6 |
Belohnungen
Risikoanalyse
DXCO3 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Dexco S.A. Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | R$4.97 |
| 52-Wochen-Hoch | R$6.22 |
| 52-Wochen-Tief | R$4.43 |
| Beta | 0.44 |
| 1 Monat Veränderung | 4.41% |
| 3 Monate Veränderung | 2.47% |
| 1 Jahr Veränderung | -2.17% |
| 3 Jahre Veränderung | -33.42% |
| 5 Jahre Veränderung | -69.47% |
| Veränderung seit IPO | -25.35% |
Aktuelle Nachrichten und Updates
Narrativ-Update • Jun 16
DXCO3: Board Refresh And Margin Outlook Will Support Future Upside
Analysts have maintained their R$9.00 price target for Dexco, noting only minor changes to assumptions for discount rate, revenue growth, profit margin and future P/E that do not materially change their view of the stock. What's in the News Dexco has scheduled a Board Meeting for May 4, 2026, at 12:00 Coordinated Universal Time.Narrativ-Update • Jun 01
DXCO3: Higher Margin Outlook And Governance Reset Will Support Upside
Analysts have adjusted their R$ price target for Dexco, citing updated assumptions for discount rate, revenue growth, profit margin, and future P/E that keep fair value around R$9,00 while refining the risk and earnings profile behind that estimate. What's in the News Dexco has scheduled a Board Meeting for May 4, 2026, at 12:00 UTC, focused on board and executive appointments.Analyseartikel • May 18
Dexco's (BVMF:DXCO3) Weak Earnings May Only Reveal A Part Of The Whole Picture
Dexco S.A.'s ( BVMF:DXCO3 ) stock showed strength, with investors undeterred by its weak earnings report. We think that...
Narrativ-Update • May 02
DXCO3: Future Stock Split Will Support More Attractive Multiple Repricing Outlook
Analysts have raised their price target on Dexco from approximately R$7.16 to about R$7.28, citing updated assumptions regarding the discount rate, revenue growth, profit margins and future P/E multiples. Valuation Changes Fair Value: R$7.16 to R$7.28, representing a small upward adjustment in the modelled target price range.Recent updates
Narrativ-Update • Jun 16
DXCO3: Board Refresh And Margin Outlook Will Support Future Upside
Analysts have maintained their R$9.00 price target for Dexco, noting only minor changes to assumptions for discount rate, revenue growth, profit margin and future P/E that do not materially change their view of the stock. What's in the News Dexco has scheduled a Board Meeting for May 4, 2026, at 12:00 Coordinated Universal Time.Narrativ-Update • Jun 01
DXCO3: Higher Margin Outlook And Governance Reset Will Support Upside
Analysts have adjusted their R$ price target for Dexco, citing updated assumptions for discount rate, revenue growth, profit margin, and future P/E that keep fair value around R$9,00 while refining the risk and earnings profile behind that estimate. What's in the News Dexco has scheduled a Board Meeting for May 4, 2026, at 12:00 UTC, focused on board and executive appointments.Analyseartikel • May 18
Dexco's (BVMF:DXCO3) Weak Earnings May Only Reveal A Part Of The Whole Picture
Dexco S.A.'s ( BVMF:DXCO3 ) stock showed strength, with investors undeterred by its weak earnings report. We think that...Narrativ-Update • May 02
DXCO3: Future Stock Split Will Support More Attractive Multiple Repricing Outlook
Analysts have raised their price target on Dexco from approximately R$7.16 to about R$7.28, citing updated assumptions regarding the discount rate, revenue growth, profit margins and future P/E multiples. Valuation Changes Fair Value: R$7.16 to R$7.28, representing a small upward adjustment in the modelled target price range.Narrativ-Update • Apr 18
DXCO3: Higher Revenue Outlook And Richer Future P/E Will Support Upside
Analysts have raised their valuation of Dexco, increasing the fair value estimate from R$8.70 to R$9.00. The change reflects updated assumptions that include higher revenue growth expectations, a lower discount rate and a richer future P/E multiple, partly offset by a lower projected profit margin.Narrativ-Update • Apr 04
DXCO3: Future Stock Split Will Support A More Attractive Repricing Outlook
Analysts have slightly adjusted their R$ price target on Dexco, citing updated assumptions that combine a different fair value estimate with changes to revenue growth, profit margin expectations and a higher future P/E multiple. Valuation Changes Fair Value: R$7.22 in the previous model compared with R$7.16 in the updated assumptions.
Narrativ-Update • Mar 21
DXCO3: Planned Stock Split And Margin Outlook Will Support Future Upside
Analysts have kept their R$ fair value estimate for Dexco steady at R$5.36. Updated assumptions reflect a slightly higher discount rate, a marginally lower revenue growth outlook, a modestly stronger profit margin, and a similar future P/E expectation.Narrativ-Update • Mar 06
DXCO3: Planned Stock Split Will Support Positive Long Term Outlook
Analysts have revised their R$ price target for Dexco slightly, with the change grounded in updated assumptions that include a different discount rate, adjusted revenue growth and profit margin expectations, and a revised future P/E multiple. What's in the News Dexco plans a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).Narrativ-Update • Feb 20
DXCO3: Future Stock Split Will Support A More Attractive Share Repricing
Analysts have trimmed their R$ price target for Dexco, reflecting a slightly lower fair value estimate alongside updated assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News Dexco announced a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).Narrativ-Update • Feb 06
DXCO3: Stock Split And Conservative Earnings Profile Will Support Future Upside
Analysts have reduced their fair value estimate for Dexco from about $8.81 to $8.70 per share. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E, which collectively indicate a more conservative earnings profile than previously estimated.Narrativ-Update • Jan 23
DXCO3: Future Split And Revised Assumptions Will Shape Balanced Outlook
Analysts have reduced their fair value estimate for Dexco from US$6.00 to US$5.36, citing updated assumptions for revenue growth, profit margins, the discount rate, and a lower future P/E multiple. What's in the News Dexco has announced a stock split or significant stock dividend with a 1.12 to 1 ratio, scheduled for December 26, 2025 (Key Developments).Analyseartikel • Jan 23
Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Narrativ-Update • Jan 08
DXCO3: Future Margins And Stock Split Plan Will Support Upside
Analysts have adjusted their price target for Dexco, reflecting a fair value change from $9.83 to $8.81. This shift is tied to updated assumptions for revenue growth, profit margins and future P/E expectations.Analyseartikel • Dec 25
Dexco S.A. (BVMF:DXCO3) Not Flying Under The Radar
With a price-to-earnings (or "P/E") ratio of 41.1x Dexco S.A. ( BVMF:DXCO3 ) may be sending very bearish signals at the...Narrativ-Update • Dec 23
DXCO3: Stronger Future Margins And Investor Day May Drive Upside
Analysts have adjusted their price target on Dexco from R$10.00 to roughly R$9.83 per share. This reflects slightly lower revenue growth assumptions, stronger expected profit margins, and a more conservative future valuation multiple.Analyseartikel • Nov 13
Earnings Troubles May Signal Larger Issues for Dexco (BVMF:DXCO3) Shareholders
A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. We think that...Analyseartikel • Oct 06
Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Narrativ-Update • Sep 06
Urbanization Trends And Digital Platforms Will Expand Market Reach
With both revenue growth and net profit margin forecasts holding steady, Dexco’s analyst consensus fair value remains unchanged at R$8.00. Valuation Changes Summary of Valuation Changes for Dexco The Consensus Analyst Price Target remained effectively unchanged, at R$8.00.Analyseartikel • Mar 21
Dexco's (BVMF:DXCO3) Anemic Earnings Might Be Worse Than You Think
A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. Our analysis...Analyseartikel • Mar 15
Dexco S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Shareholders might have noticed that Dexco S.A. ( BVMF:DXCO3 ) filed its full-year result this time last week. The...
Neues Narrativ • Mar 10
New Ceramic Tiles Factory In Botucatu Will Improve Future Operations
Streamlining of operations could enhance focus on core areas, boosting profitability and improving net margins.Analyseartikel • Feb 12
Here's Why Dexco (BVMF:DXCO3) Has A Meaningful Debt Burden
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analyseartikel • Dec 20
Is Dexco S.A. (BVMF:DXCO3) Potentially Undervalued?
While Dexco S.A. ( BVMF:DXCO3 ) might not have the largest market cap around , it saw significant share price movement...Analyseartikel • Dec 02
There's Reason For Concern Over Dexco S.A.'s (BVMF:DXCO3) Price
When close to half the companies in Brazil have price-to-earnings ratios (or "P/E's") below 8x, you may consider Dexco...Analyseartikel • Oct 26
Is Dexco (BVMF:DXCO3) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyseartikel • Aug 10
Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results
Shareholders of Dexco S.A. ( BVMF:DXCO3 ) will be pleased this week, given that the stock price is up 12% to R$8.05...Analyseartikel • Aug 08
Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching
Dexco S.A. ( BVMF:DXCO3 ), is not the largest company out there, but it saw a decent share price growth of 14% on the...Analyseartikel • Jul 19
Returns On Capital At Dexco (BVMF:DXCO3) Have Stalled
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...Analyseartikel • May 13
Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts
Last week saw the newest quarterly earnings release from Dexco S.A. ( BVMF:DXCO3 ), an important milestone in the...Analyseartikel • May 04
Is It Time To Consider Buying Dexco S.A. (BVMF:DXCO3)?
Dexco S.A. ( BVMF:DXCO3 ), is not the largest company out there, but it saw a double-digit share price rise of over 10...Analyseartikel • Apr 15
Slowing Rates Of Return At Dexco (BVMF:DXCO3) Leave Little Room For Excitement
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Analyseartikel • Mar 14
Dexco's (BVMF:DXCO3) Earnings Might Not Be As Promising As They Seem
Shareholders didn't seem to be thrilled with Dexco S.A.'s ( BVMF:DXCO3 ) recent earnings report, despite healthy profit...Analyseartikel • Jan 19
Dexco S.A.'s (BVMF:DXCO3) Earnings Are Not Doing Enough For Some Investors
With a price-to-earnings (or "P/E") ratio of 7.5x Dexco S.A. ( BVMF:DXCO3 ) may be sending bullish signals at the...Analyseartikel • Jan 04
Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analyseartikel • Dec 04
At R$7.43, Is Dexco S.A. (BVMF:DXCO3) Worth Looking At Closely?
Dexco S.A. ( BVMF:DXCO3 ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in...Analyseartikel • Oct 08
Returns Are Gaining Momentum At Dexco (BVMF:DXCO3)
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Analyseartikel • Sep 13
Is Dexco (BVMF:DXCO3) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Aktionärsrenditen
| DXCO3 | BR Forestry | BR Markt | |
|---|---|---|---|
| 7D | 2.9% | -3.8% | 1.1% |
| 1Y | -2.2% | -21.0% | 11.5% |
Rendite im Vergleich zur Industrie: DXCO3 übertraf die Branche BR Forestry , die im vergangenen Jahr eine Rendite von -21 erzielte.
Rendite vs. Markt: DXCO3 hinter dem Markt BR zurück, der im vergangenen Jahr eine Rendite von 11.5 erzielte.
Preisvolatilität
| DXCO3 volatility | |
|---|---|
| DXCO3 Average Weekly Movement | 5.6% |
| Forestry Industry Average Movement | 5.2% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in BR Market | 7.9% |
| 10% least volatile stocks in BR Market | 1.9% |
Stabiler Aktienkurs: DXCO3 hatte in den letzten 3 Monaten im Vergleich zum BR -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: DXCO3Die wöchentliche Volatilität (6%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1951 | n/a | Raul Guaragna | ri.dex.co |
Dexco S.A. ist zusammen mit seinen Tochtergesellschaften in der Produktion und dem Verkauf von Holzplatten in Brasilien und international tätig. Das Unternehmen ist in den Segmenten Holz, Deca und Beschichtungen tätig. Das Unternehmen bietet unter der Marke Duratex Platten mit mittlerer Dichte sowie Platten mit mittlerer und hoher Faserdichte, unter dem Markennamen Durafloor Laminatfußböden und halbfertige Komponenten für Möbel sowie unter den Marken Deca, Hydra, Belize, Elizabeth und Hydra Corona Glasporzellan, Metallbadarmaturen und Duschen an.
Dexco S.A.'s Grundlagenzusammenfassung
| DXCO3 grundlegende Statistiken | |
|---|---|
| Marktanteil | R$4.49b |
| Gewinn(TTM) | R$8.59m |
| Umsatz(TTM) | R$8.36b |
525.4x
Kurs-Gewinn-Verhältnis 0.5x
Kurs-Umsatz-VerhältnisIst DXCO3 zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| DXCO3 Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | R$8.36b |
| Kosten der Einnahmen | R$6.35b |
| Bruttogewinn | R$2.01b |
| Sonstige Ausgaben | R$2.01b |
| Gewinn | R$8.59m |
Zuletzt gemeldete Gewinne
Mar 31, 2026
Datum des nächsten Gewinnberichts
Aug 06, 2026
| Gewinn per Aktie (EPS) | 0.0095 |
| Bruttomarge | 24.09% |
| Nettogewinnspanne | 0.10% |
| Schulden/Eigenkapital-Verhältnis | 114.7% |
Wie hat sich DXCO3 auf lange Sicht entwickelt?
Historische Performance und VergleicheUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/06/30 23:20 |
| Aktienkurs zum Tagesende | 2026/06/30 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details des Analysemodells, das zur Erstellung dieses Berichts verwendet wurde, sind auf unserer GitHub-Seite verfügbar. Außerdem haben wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf YouTube.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Dexco S.A. wird von 15 Analysten beobachtet. 9 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Guilherme Rosito | BofA Global Research |
| Rafael Barcellos | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |
| Carlos Palhares Sequeira | BTG Pactual |